The Nucleoside hydrolase DNA vaccine VR1012NH36 in prophylactic vaccination against mice tegumentar leishmaniasis

Procedia in Vaccinology

Volumn 1, Issue 1, 2009, Pages 120-123

  Souza, L O P ^a   Palatnik de Sousa, C B ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

croos protection; DNA vaccine; FML antigen; Leishmania amazonensis; Leishmanioses; Nucleoside hydrolase; Quillaja saponaria saponin; species specificty

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; NUCLEOSIDASE; PARASITE ANTIGEN; SAPONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DNA IMMUNIZATION; FOOT PAD; IMMUNOPROPHYLAXIS; IMMUNOTHERAPY; LEISHMANIA; LEISHMANIA CHAGASI; LEISHMANIA MEXICANA; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMASTIGOTE; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

EID: 71649102076     PISSN: 1877282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.provac.2009.07.022     Document Type: Article

References (6)

1. Lukes J., Mauricio I.L., Schönian G., Dujardin J.C., Soteriadou K., Dedet J.P., et al. Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy. Proc Natl Acad Sci U S A 104 (2007) 9375-9380
2. Santana D.M., Paraguai de Souza E., Borja-Cabrera G.P., Sturm N.R., Palatnik de Sousa C.B., and Campbell D.A. Nucleoside Hydrolase from Leishmania (L) donovani is an Antigen Diagnostic for Visceral Leishmaniasis. Mol Biochem Parasitol 120 (2002) 315-319
3. ® vaccine against canine visceral leishmaniasis in Brazil. Vaccine 26 (2008) 4991-4997
4. Aguilar-Be I., Rosado-Vallado M., Mut-Martin M., Garcia-Miss M.R., Palatnik-de-Sousa C.B., and Dumonteil E. Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis. Inf Immun 73 (2005) 812-819
5. Gamboa-León R., Paraguai de Souza E., Borja Cabrera G.P., Santos F.N., Miyashiro L.M., Pinheiro R.O., et al. Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of L. donovani. Vaccine 24 (2006) 4863-4873
6. Borja-Cabrera; Santos FB, Picillo E, Gravino AE, Manna L, Palatnik-de-Sousa CB. Nucleoside hydrolase DNA vaccine against canine visceral leishmaniasis (CVL). Abstracts of the Vaccine 2 Global Congress, 2008, Boston USA.177.